Omnipod Insulin Pump Injury & Wrongful Death Lawsuit Lawyers

Omnipod Insulin Pump Recall Lawsuit: Nearly 30 Serious Injuries Linked To Insulin Underdosing Risk

What Parker Waichman LLP Found

• Defective pods may leak insulin internally, causing underdosing.
• Users may not receive alerts when the device fails.
• Underdosing can lead to dangerous hyperglycemia and DKA.
• Nearly 30 serious injuries have already been reported.
• Affected individuals may have grounds to file a lawsuit.

A nationwide safety alert involving insulin delivery devices has raised serious concerns for individuals managing diabetes. Federal health officials reported that certain Omnipod 5 insulin delivery pods may contain a defect that interferes with proper insulin delivery. These pods are widely used by individuals with both type 1 and type 2 diabetes, making this issue particularly alarming due to the reliance on consistent and accurate insulin dosing.

The recall affects specific lots of pods that may contain a small tear in the internal tubing. This defect can allow insulin to leak within the device instead of being delivered into the body. When insulin is not properly administered, blood glucose levels can rise quickly, leading to serious medical complications.

Reports submitted to regulators show that nearly 30 individuals have already suffered serious injuries connected to this issue. These incidents include hospitalization and dangerous conditions such as diabetic ketoacidosis. Although no deaths have been reported, the risk remains significant, especially for individuals who depend on these devices for daily glucose control.

Because these devices are designed to function automatically, many users rely on them without constant manual monitoring. A defect that disrupts insulin delivery without obvious warning can create a dangerous situation. Individuals across the country who used affected pods may have been exposed to preventable harm.

What Caused The Insulin Pod Recall

The recall centers on a manufacturing defect within certain Omnipod 5 insulin pods. According to regulators, a small tear may form in the internal tubing that carries insulin from the pod reservoir to the infusion site. This seemingly minor defect can have serious consequences.

When the tubing is compromised, insulin may leak inside the pod instead of being delivered into the body. This leads to underdosing, meaning the user receives less insulin than required to control blood sugar levels.

Insulin therapy depends on precision. Even small inconsistencies in dosage can disrupt glucose control. When insulin delivery drops below necessary levels, blood sugar can rise rapidly.

The issue becomes more concerning because users may not immediately notice the problem. The device may continue operating without visible signs of failure, allowing blood sugar levels to increase over time without intervention.

This type of defect raises questions about product design, quality control, and testing procedures before distribution. When a medical device fails in a way that is not easily detectable, the potential for harm increases significantly.

Why Insulin Underdosing Is Dangerous

Insulin plays a critical role in regulating blood glucose levels. When insulin is not delivered properly, the body cannot process glucose effectively. This leads to hyperglycemia, a condition characterized by elevated blood sugar levels.

Short-term symptoms of hyperglycemia may include:

• Frequent urination
• Increased thirst
• Fatigue
• Blurred vision
• Headaches

If left untreated, hyperglycemia can progress into diabetic ketoacidosis (DKA), a severe and potentially life-threatening condition. DKA occurs when the body begins breaking down fat for energy due to insufficient insulin. This process produces ketones, which can accumulate in the bloodstream and cause dangerous chemical imbalances.

DKA symptoms may include:

• Severe nausea and vomiting
• Abdominal pain
• Confusion
• Rapid breathing
• Loss of consciousness

Hospitalization is often required to treat DKA. Without timely medical care, the condition can become fatal.

For individuals using automated insulin delivery systems, consistent dosing is essential. Any disruption in insulin flow can lead to rapid deterioration in health, particularly for those with type 1 diabetes.

Lack Of Warning Signs In Defective Pods

One of the most concerning aspects of this recall is the possibility that affected pods may fail without triggering an alarm. While some leaks may activate a hazard alert, others may not produce any warning at all.

Users may believe their device is functioning properly while receiving insufficient insulin. This false sense of security can delay corrective action and increase the risk of complications.

Additionally, the risk may increase if individuals use multiple defective pods consecutively. This can result in prolonged periods of underdosing, further elevating blood sugar levels and increasing the likelihood of severe outcomes.

Medical device users are often trained to rely on alerts and system notifications. When those alerts fail, users may not detect the problem until symptoms become severe.

This failure to provide consistent warning signals raises concerns about the reliability of the device and whether adequate safeguards were in place.

Scope Of The Recall And Affected Products

The recall involves 49 specific lots of Omnipod 5 insulin pods. These pods are part of a widely used automated insulin delivery system designed to provide continuous insulin administration for up to 72 hours.

The system is commonly paired with continuous glucose monitoring devices, which track blood sugar levels in real time. However, the recall does not affect the glucose monitoring systems themselves.

Because the pods are worn continuously and replaced every few days, many individuals may have used multiple affected units before becoming aware of the issue.

The widespread distribution of these products means individuals across the country may have been affected. Anyone using Omnipod 5 pods during the relevant timeframe should verify whether their devices were part of the recalled lots.

Injuries And Reported Complications

Reports submitted to regulators indicate that at least 29 serious injuries have been linked to the defective pods. These cases include:

• Hospitalization due to high blood sugar.
• Development of diabetic ketoacidosis.
• Severe hyperglycemia requiring emergency treatment.

Although no deaths have been reported, the severity of these conditions cannot be understated. DKA and uncontrolled hyperglycemia can escalate quickly and require immediate medical attention.

Many individuals rely on insulin delivery systems to maintain stable health. When these systems fail, the consequences can be immediate and severe.

In some cases, users may not connect their symptoms to the device malfunction right away. This can delay treatment and worsen outcomes.

Legal Claims Involving Defective Insulin Devices

Consumers harmed by defective medical devices may have the right to pursue legal action. When a device fails due to a manufacturing defect or design flaw, the company responsible may be held accountable.

Potential legal claims may include:

• Product liability
• Defective design
• Manufacturing defect
• Failure to warn
• Negligence

Manufacturers have a duty to ensure that medical devices are safe for their intended use. They must also provide clear warnings about potential risks.

When a device delivers less medication than intended without warning, it may be considered unreasonably dangerous. Individuals who suffered harm as a result may be entitled to compensation.

Damages in these cases may include:

• Medical expenses
• Hospitalization costs
• Lost income
• Pain and suffering
• Long-term health complications

Because this issue involves a nationwide recall, affected individuals across multiple states may be eligible to file claims.

Insulin Pod Lawsuit FAQs

Can I File A Lawsuit If I Used A Recalled Insulin Pod?

Yes, if you used an affected pod and experienced complications such as high blood sugar, hospitalization, or diabetic ketoacidosis, you may have a legal claim. Medical records and device history can help establish the connection between the defect and your injuries.

What If I Experienced Symptoms But Was Not Hospitalized?

You may still have a claim. Even if your symptoms did not require hospitalization, medical treatment, missed work, or ongoing health concerns may be considered when evaluating your case.

Who Can Be Held Responsible For Defective Insulin Pods?

Liability may extend to the manufacturer, distributors, and other parties involved in bringing the product to market. The specific facts of your case will determine which parties may be responsible.

What Compensation Can I Recover?

Compensation may include medical bills, emergency care costs, lost wages, pain and suffering, and future medical needs. Each case is different and depends on the severity of the injury.

How Do I Know If My Pods Were Part Of The Recall?

You can check the lot number on your product packaging and compare it to the recalled lots. Healthcare providers and manufacturers may also provide guidance.

Contact Parker Waichman LLP For A Free Case Review

If you or a loved one used an Omnipod 5 insulin pod and experienced high blood sugar, hospitalization, or diabetic ketoacidosis, you may have legal rights. Defective medical devices can cause serious harm, especially when they fail without warning.

Parker Waichman LLP is investigating claims involving defective insulin pods and may be able to help you recover compensation for your injuries.

Call 1-800-YOUR-LAWYER (1-800-968-7529) for a free consultation today. Regardless of your location or where your injury occurred, our nationwide product injury law firm is ready to assist you.